Literature DB >> 31111353

Predicting Outcome in Mammary Phyllodes Tumors: Relevance of Clinicopathological Features.

Joshua Li1, Julia Y Tsang1, Clement Chen2, Siu-Ki Chan3, Sai-Yin Cheung4, Cherry Wu5, Ava Kwong2, Jintao Hu6, Hong Hu7, Dongxian Zhou7, Gary M Tse8.   

Abstract

BACKGROUND: Phyllodes tumors (PTs) of the breast are uncommon fibroepithelial neoplasms. Most behave in a benign fashion but they also have the potential to recur locally or to metastasize.
METHODS: In the current study involving 290 PTs (181 benign, 76 borderline, and 33 malignant) from three hospitals over an 11-year period, we assessed the relationship between histologic parameters (including histologic features affecting grade and surgical margin status), postoperative adjuvant treatment, and local recurrences and distant metastases.
RESULTS: An involved surgical margin was the only factor associated with increased risk of local recurrences (hazard ratio [HR] 4.673, p = 0.003), but not for distant metastases. For local recurrences, a wider margin did not confer additional benefits. None of the histologic factors were predictive for local recurrences. In contrast, distant metastases were correlated with histologic parameters, particularly an infiltrative border (HR 10.935, p = 0.012) and the presence of necrosis (HR 15.311, p = 0.007). In this series, all local recurrences were found in patients without radiotherapy, regardless of surgical margin status.
CONCLUSION: A negative surgical margin is mandatory for the effective local control of PT recurrence, and a minimal margin clearance may be sufficient. For distant metastases, the inherent characteristics of PTs are important, thus it may be prudent to evaluate additional histologic features, including necrosis, for patients' prognostication.

Entities:  

Mesh:

Year:  2019        PMID: 31111353     DOI: 10.1245/s10434-019-07445-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Surgical management in phyllodes tumors of the breast: a systematic review and meta-analysis.

Authors:  Yufan Wei; Yanying Yu; Yashuang Ji; Yuting Zhong; Ningning Min; Huayu Hu; Qingyu Guan; Xiru Li
Journal:  Gland Surg       Date:  2022-03

2.  Phyllodes Tumors of the Breast: A Single-Center Experience.

Authors:  Sevda Yılmaz; Muhammed Rasid Aykota; Yeliz Arman Karakaya; Utku Özgen; Ergün Erdem
Journal:  Eur J Breast Health       Date:  2020-12-24

3.  Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast.

Authors:  Xiaoguang Li; Nianping Jiang; Chunlai Zhang; Xiangguo Luo; Peng Zhong; Jingqin Fang
Journal:  Cancer Imaging       Date:  2021-03-12       Impact factor: 3.909

4.  The Potential Value of Texture Analysis Based on Dynamic Contrast-Enhanced MR Images in the Grading of Breast Phyllode Tumors.

Authors:  Xiaoguang Li; Hong Guo; Chao Cong; Huan Liu; Chunlai Zhang; Xiangguo Luo; Peng Zhong; Hang Shi; Jingqin Fang; Yi Wang
Journal:  Front Oncol       Date:  2021-11-10       Impact factor: 6.244

5.  Morphological features of 52 cases of breast phyllodes tumours with local recurrence.

Authors:  Jiaxin Bi; Mumin Shao; Hongping Tang; Xiao Lin; Xuewen Yu; Yingying Liang; Lu Zhang; Zhixin Li
Journal:  Virchows Arch       Date:  2022-07-29       Impact factor: 4.535

Review 6.  Phyllodes Tumors: A Scoping Review of the Literature.

Authors:  Jessica Bogach; Saad Shakeel; Frances C Wright; Nicole J Look Hong
Journal:  Ann Surg Oncol       Date:  2021-07-22       Impact factor: 5.344

7.  Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.

Authors:  Elisabetta Di Liso; Michele Bottosso; Marcello Lo Mele; Vassilena Tsvetkova; Maria Vittoria Dieci; Federica Miglietta; Cristina Falci; Giovanni Faggioni; Giulia Tasca; Carlo Alberto Giorgi; Tommaso Giarratano; Eleonora Mioranza; Silvia Michieletto; Tania Saibene; Angelo Paolo Dei Tos; PierFranco Conte; Valentina Guarneri
Journal:  ESMO Open       Date:  2020-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.